Identification et caractérisation de nouveaux inhibiteurs peptidiques de la protéase 2A du rhinovirus humain

Abstract : Human rhinoviruses (HRV) remain a significant public health problem as they are the major cause of both upper and lower respiratory tract infections. To date no vaccine or antiviral are available against these pathogens. Using a high-throughput yeast two-hybrid screening, we identified a six amino acid “hit” peptide, LVLQTM, which acted as a pseudo-substrate of the viral 2A cysteine protease (2Apro) and inhibited its activity. This peptide was chemically modified at its C-terminus with a reactive electrophilic fluoromethylketone group to form a covalent linkage with the nucleophilic active site thiol of the enzyme. Ex vivo and in vivo experiments showed that thus converted, LVLQTM was a strong inhibitor of HRV replication in both A549 cells and mice. Based on HRV-2 2Apro crystallographic data, a virtual docking model was then set up to predict the inhibitor binding mode into the ligand binding pocket of the enzyme. Sequence comparison between different 2Apro from HRV-A, -B and –C species revealed that the aminoacid residues involved in the interaction with the inhibitor are relatively well conserved. If our peptide inhibitor seemed to be of general use against all HRV serotypes, its use for therapeutic purposes could be extended to other enterovirus-associated diseases since it was also active against Human Enterovirus 71 (EV-71) 2A proteases and EV-71 replication. Moreover, comparison of the sequence of these proteases with the one of HRV-A2 revealed only minor differences in the residues involved in the interaction with LVLQTM. Therefore, this study opens new doors in the development of an antiviral against a wide range of enteroviruses
Document type :
Complete list of metadatas
Contributor : Abes Star <>
Submitted on : Tuesday, July 7, 2015 - 8:53:06 AM
Last modification on : Wednesday, June 13, 2018 - 1:07:31 AM
Long-term archiving on : Wednesday, April 26, 2017 - 12:33:53 AM


Version validated by the jury (STAR)


  • HAL Id : tel-01172178, version 1



Nisrine Falah. Identification et caractérisation de nouveaux inhibiteurs peptidiques de la protéase 2A du rhinovirus humain. Médecine humaine et pathologie. Université Claude Bernard - Lyon I, 2013. Français. ⟨NNT : 2013LYO10027⟩. ⟨tel-01172178⟩



Record views


Files downloads